Navigation Links
Drugs in Biological Technology

Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets

... a growing developer and producer of prescriptions drugs and licensed national seller of ... technologies in the preclinical development of drugs to maximize market exposure. We believe ... a growing developer and producer of prescription drugs and a licensed national seller of pharmaceutical ...

Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic

... with a focus on the development of prescription drugs that target unmet medical needs, and MSM Protein ... with a focus on the development of prescription drugs that target unmet medical needs. It develops its ... power and sensitivity to the search for antibody drugs to multispanners. For more information on ...

Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... in July 2009. The Company also has several drugs in earlier stages of clinical development for the ...

$10,000 ISSAC Award for Innovation Presented to MIT PhD

... of implantable medical devices that release drugs into the body in a controlled manner. Combination ... like a pump, using osmotic pressure to release drugs into the bladder. The size of the device, which ... Once implanted, the system is designed to deliver drugs into the bladder for a specific period of time. ...

Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing

... drug pipeline we expect to in-license additional drugs in the near future; SG410 is anticipated to be ... technology should change the way in which cancer drugs are developed." For more information ... human cancer biology and their response to drugs is predictive of clinical outcomes in cancer ...

Supelco(R) and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water

... extraction of non-steroidal anti-inflammatory drugs (NSAIDs). "SupelMIP NSAIDS is an ... appearance of prescription and over-the-counter drugs in environmental water," said Anthony Rees, CEO ... and concentrations of the most frequently used drugs having the potential for adverse effects. This ...

Thomson Reuters Partners With Sagient Research

... and approval timelines on clinical-stage drugs into the upcoming Forecast Module of Thomson ... customers need to assess sales potential of new drugs more often than ever before," said Jon ... partnerships, including detailed information on drugs in development, their market potential, the ...

New method may accelerate drug discovery for difficult diseases like Parkinson's

... in almost every cellular process. Most current drugs act by wedging themselves into small pockets on ... of target proteins. However, these traditional drugs are unable to adhere to smooth, flat protein surfaces, rendering the drugs ineffective for inhibiting the key interactions ...

Novel drug discovery tool could identify promising new therapies for Parkinson's disease

... chemists capable of rapidly searching for drugs to treat Parkinson's disease. In a study ... synthetic precursor of dopamine called L-DOPA or drugs that mimic dopamine's action can provide ... from Parkinson's disease. Unfortunately, these drugs lose much of their effectiveness in later stages ...

REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients

... Information Suicidality and Antidepressant drugs Antidepressants increased the risk compared to ... placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and ...

Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the ...

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

... absorption of peptides and other sensitive drugs that cannot otherwise be given orally. "The ... be applicable to a large number of water-soluble drugs including peptides that are poorly permeable, ... stable. In the LPM(TM) system, water-soluble drugs are contained in the water space in the core of ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... Cancer Therapeutics II-1 Key Prostate Cancer drugs & Companies II-2 Hormone Therapies to ... FDA Approved Prostate Cancer Hormonal Therapy drugs in the US for 2007 (includes corresponding ... II-2 Select Prostate Cancer Hormonal Therapy drugs with Year of FDA Approval II-3 Targeted ...

Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models

... the effectiveness of two standard chemotherapy drugs in mouse models of human cancers. This research ... the effectiveness of several standard anticancer drugs not only against tumors of the brain and neural tissue but also against other cancers sensitive to drugs that work by damaging DNA. Safety, of course, ...

Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

... World market for small molecule kinase inhibitor drugs is projected to reach $16.2 billion by the year ... resistance to single targeted kinase inhibitor drugs is fingered as the key reason triggering interest ... and Sutent, given the potential of these new drugs to offer the much awaited solution to the ...

Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

... of a comprehensive global report on Prescription drugs market. The global prescription drugs market is witnessing a significant deceleration ... slowing down growth in the global prescription drugs market include economic downturn, increasing ...

Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the ...

'Designer molecules' being developed to fight disease

... are developing a new way to make protein based drugs with potential applications in stroke, vascular ... in the body. These proteins can be used to make drugs as a treatment for heart disease and cancer." She said: "Whilst most drugs in current use are synthetic, these designer ...

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the ...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

... while the bioavailability of the encapsulated drugs was similar to that expected with conventional ... for both agents and accumulation of the drugs over the three dose induction course (infusions ... a novel approach that identifies molar ratios of drugs that will deliver a synergistic benefit, and ...

Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452

... side effects. The inotropic mechanism of current drugs also increases the velocity of cardiac ... A portion of that cost is attributable to drugs used to treat each of chronic and acute heart failure. Sales of drugs to treat chronic heart failure reached almost ...

As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention

... receive $195,000 to commercialize re-formulated drugs that address limitations of existing therapies. A ... to further develop a novel approach to converting drugs into dry, sterile powder form. The process is ... while easing the process of administering drugs for both physicians and patients. The investment ...

Low Occurrence of Severe Cardiac Side Effects Despite Extensive Prior Doxorubicin Treatment Reported in Pixantrone Pivotal Trial

... lymphoma (NHL) for whom anthracycline-related drugs are typically not to be used due to the increased ... of hair loss, a very common side effect of other drugs in this class. Overall, the incidence of serious ... central implanted catheter as required for other drugs in this class. About Cell Therapeutics, ....

HealthCore Responds to Need for Real-world Health Outcomes Information on Drugs and Devices with Physician Network and Prospective Effectiveness Research

... and government to understand more about how drugs and medical devices are performing in patients in ... and continued evaluation of marketed drugs and medical devices. These real-world ... allows us to deliver information on how drugs and medical devices are used in the real world to ...

Trubion Announces Acceptance of Three Presentations on Its TRU-016 Product Candidate at the 2009 ASCO Annual Meeting

... of TRU-016 in combination with other therapeutic drugs for the treatment of non-Hodgkin's lymphoma ... of TRU-016 in Combination With Other Therapeutic drugs in Models of Non-Hodgkin's Lymphoma In ... doxorubicin, rapamycin, and bendamustine. drugs were tested alone or in combination with TRU-016 ...

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... called NSAIDs (nonsteroidal anti-inflammatory drugs used to treat pain or swelling). Tell your doctor ... to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or ... to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or ...

Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma

... deliver significantly higher doses of anti-cancer drugs to a patient's liver while minimizing entry of the drugs into the rest of the patient's circulation. This ... the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of ...

Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the ...

Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010

... percent. Higher volumes of lower-priced generic drugs reduced net revenues for first-quarter 2009 by ... limited if we do not expand our existing base of drugs or if we lose patients; Our Specialty ... impacted, if the safety risk profiles of drugs increase or ...

Matt Bars, a Global Expert in Smoking Cessation, Joins Next Safety as Chairman

... allow the user to inhale nicotine vapor and other drugs from an air stream with a high degree of control ... in the US. In addition, NSI is testing other drugs that use its new pulmonary drug delivery platform ... number of leading pharmaceutical companies. These drugs include treatments for asthma, pulmonary ...

Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule

... discover and select potent and safe RNA targeted drugs within a short time span," said Henrik 0rum, ... retains the lucrative commercial rights to the drugs within Europe. The agreement included two LNA ... the development of six additional cancer target drugs selected by Enzon which are in various stages of ...

Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting

... myeloid leukemia (AML) suggesting that antisense drugs targeting STAT5 may offer a new avenue to treat ... anti-tumor activity. We believe that antisense drugs have pharmaceutical properties that make them ... expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. ...

Mylan's Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments

... the primary supplier of five antiretroviral (ARV) drugs used in second-line HIV/AIDS treatment regimens. ... Fixed-dose combinations are multiple ARV drugs combined into a single pill. UNITAID ... to increase access and reduce prices of quality drugs and diagnostics for the treatment of HIV/AIDS, ...

Accera, Inc. Launches Neuera Pharmaceuticals, Inc.

... and development of proprietary small molecule drugs for acute and chronic neurological conditions ... the discovery and development of small molecule drugs for the treatment of neurodegenerative diseases ... platform for hypometabolism, Neuera is developing drugs for Parkinson's disease, Huntington's disease, ...

Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business

... human cancer biology and their response to drugs is predictive of clinical outcomes in cancer ... a portfolio of novel therapeutic candidates. As drugs progress through preclinical development, the ... care and to Companies for evaluation of oncology drugs in models that integrate prognostic testing with ...

Chimerix Joins International Network of Organizations to Cure Malaria

... that could be developed into highly effective drugs to treat malaria. We are delighted to be working ... can be applied to new drug moieties or known drugs to improve dosing parameters, broaden therapeutic ... and deliver effective and affordable antimalarial drugs through public-private partnerships. MMV is ...

Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine 'Notable People in R&D'

... team." He continued, "The abuse of prescription drugs has become a serious concern for healthcare ... with a scientific basis on which to schedule drugs and helps prevent the devastating effects of ... and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. ...

Isis Pharmaceuticals to Present at the 4th Annual Citi Biotech Day

... expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. ... the world's first antisense drug and has 19 drugs in development. Isis' drug development programs ... Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of ...

Publication of Shire plc's Annual Report 2008

... If the parallel importation of lower priced drugs is permitted in the US, it could have the effect of reducing sales of equivalent drugs in the US. To the extent that parallel ... The parallel importation of prescription drugs is relatively common within the EU. A ...

Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology

... science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax ... inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the ...
Other Contents
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   ... platform built for the post-password and Internet of Things ... additional seed funding. The venture round was led by ... Pantera Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey ... the new funding to expand its team and bring ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/11/2014)... -- That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ... best ways to treat it. For example, a ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
(Date:12/22/2014)... 2014 Explorys, the leader in big ... leadership team: Greg Yarrington as Vice President of Operations, ... Wells as Vice President of Solutions. These new leaders ... jobs in 2015 to support client demand for the ... offerings, and growth of its partner network. , ...
(Date:12/22/2014)... 2014 Pasadena sleep apnea ... sleep apnea. Drowsy drivers are 15 times more likely ... well-rested, and some experts believe that sleep-deprived drivers may ... drivers. Unfortunately, millions of Americans may be sleep-deprived without ... Sleep Medicine, about 18 million Americans have sleep apnea, ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Christmas is days ... has a fast and easy solution that will please: the ... can be purchased from from $25 up to $350," says ... 100% customer satisfaction and a wide array of skin care ... fees and no expiration dates. , Gift delivery past ...
(Date:12/22/2014)... Washington, DC (PRWEB) December 22, 2014 ... Nursing Leadership Conference, next month in San ... strategies to address dynamics that often stand in ... authority, and competition. , This premier faculty ... Center for Transformational Leadership, whose mission is to ...
(Date:12/21/2014)... 2014 BellasDress.com offers a wide range ... Today, it announces its BellasDress Christmas Sale , ... online store. , BellasDress is a famous online supplier ... fans through a series of promotions. The dress experts ... , “We are proud of offering high quality ...
Breaking Medicine News(10 mins):Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:BellasDress.com Announces its BellasDress Christmas Sale 2
Other TagsOther Tags